These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12869213)

  • 1. Myocardial expression of baculoviral p35 alleviates doxorubicin-induced cardiomyopathy in rats.
    Date T; Luo Z; Yamakawa M; Belanger AJ; Scaria A; Cheng SH; Gregory RJ; Mochizuki S; Jiang C
    Hum Gene Ther; 2003 Jul; 14(10):947-57. PubMed ID: 12869213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated expression of p35 prevents hypoxia/reoxygenation injury by reducing reactive oxygen species and caspase activity.
    Date T; Belanger AJ; Mochizuki S; Sullivan JA; Liu LX; Scaria A; Cheng SH; Gregory RJ; Jiang C
    Cardiovasc Res; 2002 Aug; 55(2):309-19. PubMed ID: 12123770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking caspase-activated apoptosis improves contractility in failing myocardium.
    Laugwitz KL; Moretti A; Weig HJ; Gillitzer A; Pinkernell K; Ott T; Pragst I; Städele C; Seyfarth M; Schömig A; Ungerer M
    Hum Gene Ther; 2001 Nov; 12(17):2051-63. PubMed ID: 11747596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of baculoviral p35 by adenoviral vector protects human cerebral neurons from apoptosis.
    Miagkov A; Turchan J; Nath A; Drachman DB
    DNA Cell Biol; 2004 Aug; 23(8):496-501. PubMed ID: 15307952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation.
    Kunisada K; Tone E; Negoro S; Nakaoka Y; Oshima Y; Osugi T; Funamoto M; Izumi M; Fujio Y; Hirota H; Yamauchi-Takihara K
    Cardiovasc Res; 2002 Mar; 53(4):936-43. PubMed ID: 11922903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis.
    Lee PJ; Rudenko D; Kuliszewski MA; Liao C; Kabir MG; Connelly KA; Leong-Poi H
    Cardiovasc Res; 2014 Mar; 101(3):423-33. PubMed ID: 24403316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies.
    Wu S; Ko YS; Teng MS; Ko YL; Hsu LA; Hsueh C; Chou YY; Liew CC; Lee YS
    J Mol Cell Cardiol; 2002 Dec; 34(12):1595-607. PubMed ID: 12505058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
    Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
    Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+.
    Doloff JC; Su T; Waxman DJ
    BMC Cancer; 2010 Sep; 10():487. PubMed ID: 20836875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol.
    Kumar D; Kirshenbaum LA; Li T; Danelisen I; Singal PK
    Antioxid Redox Signal; 2001 Feb; 3(1):135-45. PubMed ID: 11291592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
    Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from loxP-p35-transgenic mice.
    Araki T; Shibata M; Takano R; Hisahara S; Imamura Si; Fukuuchi Y; Saruta T; Okano H; Miura M
    Cell Death Differ; 2000 May; 7(5):485-92. PubMed ID: 10800082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
    Pei XM; Yung BY; Yip SP; Ying M; Benzie IF; Siu PM
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E311-23. PubMed ID: 24326424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease.
    Ziegler RJ; Li C; Cherry M; Zhu Y; Hempel D; van Rooijen N; Ioannou YA; Desnick RJ; Goldberg MA; Yew NS; Cheng SH
    Hum Gene Ther; 2002 May; 13(8):935-45. PubMed ID: 12031126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis.
    Narumi T; Shishido T; Otaki Y; Kadowaki S; Honda Y; Funayama A; Honda S; Hasegawa H; Kinoshita D; Yokoyama M; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Tanaka A; Woo CH; Abe J; Takeishi Y; Kubota I
    J Mol Cell Cardiol; 2015 May; 82():1-12. PubMed ID: 25736854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.